CompoAtlas

Morphée

Morphée, licence 80060406: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Solutions 2XL
NPN or DIN-HM
80060406
Status
Active licence
Licence date
29 April 2015
Revision date
20 January 2017
Form
Liquide oral
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
N-acétyl-5-méthoxytryptamine

Source : Mélatonine

0.6 milligrammeNot calculated

Non-medicinal ingredients

Saveur, Jus de fruit de Prunus cerasus (Griottier), Benzoate de sodium, Sodium bisulfate, Feuille de stevia rebaudiana, Eau purifiée, Sorbate de potassium

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1.0 Cuillère à thé ; maximum: 3.0 Cuillère à thé1.0 Jour(s)

Uses authorised in Canada

Aide à augmenter la durée totale du sommeil (aspect de la qualité du sommeil) chez les personnes souffrant de restriction du sommeil ou d'horaire altéré du sommeil, par exemple le travail a horaires variables et le décalage horaire. Aide à prévenir et/ou réduire les effets du décalage horaire (p. ex. fatigue diurne ou le sommeil perturbé) pour les personnes voyageant en avion vers l'est et traversant deux fuseaux horaires ou plus. Aide à réduire le temps nécessaire pour s'endormir (aspect délai d'endormissement de la qualité du sommeil) chez les personnes souffrant du syndrome de retard de phase du sommeil. Aide à rebalancer les cycles veille-sommeil (aspect du rythme circadien).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80060406

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2017. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line